secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001564590-22-024065
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals announces public offering of 7.87M shares and pre-funded warrants for net proceeds of ~$234.6M
--------------------------------------------------------------------------------

- Offering of 7,868,854 common shares and pre-funded warrants for 327,868 shares at $30.50/share and $30.4999/warrant.
- Net proceeds expected ~$234.6M after underwriting discounts and estimated expenses.
- Underwriters granted 30-day option to purchase up to 1,229,508 additional common shares at $28.67/share.
- Pre-funded warrants exercisable immediately at $0.0001 per share until exercised in full.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000156459022024065/0001564590-22-024065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000156459022024065/xene-8k_20220622.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-024065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer